Recursion is a Salt Lake City biotech company that uses AI to find and develop medicines for cancer and rare diseases. It last closed at $2.72 on Nov 17, down 6.53% on the day. The average 12-month price target from 2 analysts is $7.50 (+175.7% from the last close), with a high of $8.00 and a low of $7.00. In the past 30 days there were 8 dark pool prints totaling $1.6M, the largest $598K.
Only 2 firms rated RXRX in the past 90 days, not enough for a consensus
Average 12-month target
$7.50
▲ 175.7% upside
Based on 2 analysts who set a price target on RXRX in the past 90 days. The average target is $7.50, with a high of $8.00 and a low of $7.00, compared with the last close of $2.72.
Highest target$8.00
Average target$7.50
Lowest target$7.00
Latest rating changes
JP MorganMaintained
Nov 16Buy$7
Leerink PartnersMaintained
Sep 25Hold$8
Date
Firm
Action
Rating
Price target
Nov 16
JP Morgan
Maintained
Buy
$7
Sep 25
Leerink Partners
Maintained
Hold
$8
Loading…
Technical Analysis
RXRX · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 34% below its 20 day and 38% below its 50 day average. It is 27% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the 52 week low at $2.50, and the nearest resistance the Pivot R1 at $2.94.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 12.5%/day
Key levels
$5.2452 week high+92.6%
$3.7550 day average+37.9%
$3.6420 day average+33.8%
$3.54100 day average+30.1%
$3.46200 day average+27.2%
$3.13Swing high (Jul 27)+15.1%
$2.94Pivot R1+8.1%
$2.72Pivot+0.0%
$2.72Last close
$2.5052 week low−8.1%
$2.50Pivot S1−8.1%
Indicators
RSI (14)
33.34
Weak, oversold below 30
Neutral
MACD
-0.21
Below its signal line
Bearish
Stochastic
5.2
Near the bottom of its range
Oversold
ADX (14)
22.5
Weak trend
Williams %R
-89.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-228.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−26.1%
Change over 10 sessions
Bearish
ATR (14)
$0.34
Typical daily range, 12.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 23.4%/day
Key levels
$5.2452 week high+92.6%
$3.7550 day average+37.9%
$3.6420 day average+33.8%
$3.54100 day average+30.1%
$3.46200 day average+27.2%
$3.13Swing high (Jul 27)+15.1%
$2.94Pivot R1+8.1%
$2.72Pivot+0.0%
$2.72Last close
$2.5052 week low−8.1%
$2.50Pivot S1−8.1%
Indicators
RSI (14)
40.69
Middle of its range
Neutral
MACD
-0.06
Below its signal line
Bearish
Stochastic
15.5
Near the bottom of its range
Oversold
ADX (14)
16.5
No clear trend
Williams %R
-91.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-146.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−15.0%
Change over 10 sessions
Bearish
ATR (14)
$0.64
Typical daily range, 23.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for RXRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RXRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow RXRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RXRX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RXRX is in one of them and how their past RXRX trades turned out.
Recursion is a biotechnology company based in Salt Lake City, Utah, that uses artificial intelligence to discover and develop medicines. Its work centers on the Recursion Operating System, a platform that combines biological data, computational molecule design and clinical trial planning. The company develops its own drug candidates, mainly for cancer and rare diseases, and partners with drugmakers such as Roche, Genentech and Sanofi on discovery programs. Its medicines are aimed at patients with serious diseases that have limited treatment options.